Professor Mark Beresford

Professor Beresford studied pre-clinical at Cambridge University, clinical at Oxford University and completed his oncology training at UCL London, Charing Cross Hospital and Mount Vernon Hospital. In 2006, he was appointed Oncology Consultant at the Bristol Oncology Centre and joined Royal United Hospital Bath as Consultant Clinical Oncologist and Head of Radiotherapy

in 2011, where he continues to treat NHS patients alongside his private practice. 

He is the Regional Lead for all cancer trials completed by the West of England Research Delivery Network, founder and Chair of the UK Breast Cancer Group - which acts as a voice for breast cancer oncologists across the country and Executive Committee member of the British Uro-oncology Group.

Professor Beresford is faculty board member for the Royal College of Radiologists (RCR), Chair of the RCR management course and a previous Vice-Chair of the Cancer Research UK population studies group. He is a member of the GenesisCare UK Breast Clinical Reference Group and is a Visiting Chair at the University of Bath.

Professor Beresford specialises in the treatment of early and recurrent cancers using cutting-edge medical therapies including chemotherapy, radiotherapy, immunotherapy, radioisotopes, systemic therapies and novel hormone therapies for advanced breast cancer.

A regular speaker in the application of real-world evidence in modern oncology practice, and how this data is translated in patient treatment decisions, Professor Beresford has interests in exercise and immune responses to chemotherapy, prostate cancer biomarkers, imaging response to treatments, new chemotherapy drug trials, radiotherapy trials, mono-clonal antibody therapy trials, phase 3 trials, and national and International multi-centre trials and treatments.

He has expertise treating and supporting patients with breast cancer, prostate cancer, kidney cancer and bladder cancer patients at all stages of their cancer journey, whether before or after surgery, at recurrence, or when seeking a second opinion.  Professor Beresford is known for his compassionate, patient-centred approach offering the latest advances in cancer treatments, combining his medical expertise with evidence-based treatments which are personalised to his patient’s individual diagnosis and needs.